Immuneering (IMRX) Interest Coverage Ratio (2020 - 2026)
Immuneering (IMRX) posted quarterly Interest Coverage Ratio of 0.85 for Q1 2026, up 98.99% year-over-year from 0.43 in Q1 2025, and up 98.83% quarter-over-quarter from 72.75 in Q4 2025.
Immuneering (IMRX) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Immuneering's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 0.85 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 98.99% year-over-year to 0.85; the TTM figure through Mar 2026 stood at 3.28 (up 96.16% YoY), while the FY2025 annual figure was 0.81, up 25.49% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.85, up from 72.75 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 0.51 in Q3 2022, with the low at 107.73 in Q4 2022.
- The 5-year median for Interest Coverage Ratio is 2.48 (2024), against an average of 36.05.
- The sharpest annual moves came in 2023 and 2026: Interest Coverage Ratio tumbled 2672.66% in 2023, then jumped 98.99% in 2026.
- Immuneering's Interest Coverage Ratio stood at 107.73 in 2022, then grew by 21.43% to 84.64 in 2023, then fell by 19.46% to 101.11 in 2024, then gained by 28.05% to 72.75 in 2025, then jumped by 98.83% to 0.85 in 2026.
- Business Quant data shows IMRX's Interest Coverage Ratio at 0.85 in Q1 2026, 72.75 in Q4 2025, and 0.52 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Immuneering | 327.37 Mn | 327.37 Mn | - | -1.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.25 |
| Mar 31, 2026 | -0.85 |
| Dec 31, 2025 | -72.75 |
| Sep 30, 2025 | -0.52 |
| Jun 30, 2025 | -2.63 |
| Mar 31, 2025 | -84.36 |
| Dec 31, 2024 | -101.11 |
| Sep 30, 2024 | -2.48 |
| Jun 30, 2024 | -2.36 |
| Mar 31, 2024 | -79.57 |
| Dec 31, 2023 | -84.64 |
| Sep 30, 2023 | -1.08 |
| Jun 30, 2023 | -0.61 |
| Mar 31, 2023 | -67.76 |
| Dec 31, 2022 | -107.73 |
| Sep 30, 2022 | -0.51 |
| Jun 30, 2022 | -1.48 |
| Mar 31, 2022 | -2.44 |
| Dec 31, 2021 | -391.86 |
| Sep 30, 2021 | -0.15 |